Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
Study NCT ID:
NCT01203020
Status:
COMPLETED
Last Update Posted:
2023-07-13
First Post:
2010-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
Sponsor:
West Virginia University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WVU 11310
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None